Lite Strategy, Inc. — Director's Dealing 2024

May 20, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2024-05-16

Reporting Person: Flynn James P (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-16	Common Stock	A	7900	$3.1621	Acquired	7900	Direct

Footnotes

F1: The price reported is a weighted-average price. These shares were purchaased in multiple transactions with prices ranging from $3.11 to $3.21 per share. The reporting person undertakes to provide MEI Pharma, Inc., any security holders of MEI Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set in this Form 4.